0001225208-24-002572.txt : 20240220
0001225208-24-002572.hdr.sgml : 20240220
20240220210335
ACCESSION NUMBER: 0001225208-24-002572
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240216
FILED AS OF DATE: 20240220
DATE AS OF CHANGE: 20240220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brown Vance R
CENTRAL INDEX KEY: 0001868243
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 24656134
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0508
4
2024-02-16
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001868243
Brown Vance R
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
SVP, GC and Corp. Secretary
0
Common Stock
2024-02-16
4
M
0
1838.0000
0.0000
A
31637.0000
D
Common Stock
2024-02-16
4
F
0
540.0000
65.8200
D
31097.0000
D
Common Stock
2024-02-17
4
M
0
1000.0000
0.0000
A
32097.0000
D
Common Stock
2024-02-17
4
F
0
294.0000
65.8200
D
31803.0000
D
Common Stock
2024-02-18
4
M
0
741.0000
0.0000
A
32544.0000
D
Common Stock
2024-02-18
4
F
0
218.0000
65.8200
D
32326.0000
D
Restricted Stock Units
2024-02-16
4
M
0
1838.0000
0.0000
D
2026-02-16
Common Stock
1838.0000
3678.0000
D
Restricted Stock Units
2024-02-17
4
M
0
1000.0000
0.0000
D
2025-02-17
Common Stock
1000.0000
1000.0000
D
Deferred Stock Units
2024-02-18
4
M
0
741.0000
0.0000
D
2024-02-18
Common Stock
741.0000
0.0000
D
Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock.
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
/s/ Susan Thompson, Attorney-in-Fact
2024-02-20